These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6870220)

  • 1. Vancomycin pharmacokinetics in patients with peritonitis on peritoneal dialysis.
    Magera BE; Arroyo JC; Rosansky SJ; Postic B
    Antimicrob Agents Chemother; 1983 May; 23(5):710-4. PubMed ID: 6870220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vancomycin pharmacokinetics in patients undergoing chronic intermittent peritoneal dialysis.
    Glew RH; Pavuk RA; Shuster A; Alfred HJ
    Int J Clin Pharmacol Ther Toxicol; 1982 Dec; 20(12):559-63. PubMed ID: 7152738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peritoneal clearance and total body elimination of vancomycin during chronic intermittent peritoneal dialysis.
    Ayus JC; Eneas JF; Tong TG; Benowitz NL; Schoenfeld PY; Hadley KL; Becker CE; Humphreys MH
    Clin Nephrol; 1979 Mar; 11(3):129-32. PubMed ID: 436339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of vancomycin in patients undergoing continuous ambulatory peritoneal dialysis.
    Blevins RD; Halstenson CE; Salem NG; Matzke GR
    Antimicrob Agents Chemother; 1984 May; 25(5):603-6. PubMed ID: 6732227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vancomycin pharmacokinetics in continuous ambulatory peritoneal dialysis patients with peritonitis.
    Harford AM; Sica DA; Tartaglione T; Polk RE; Dalton HP; Poynor W
    Nephron; 1986; 43(3):217-22. PubMed ID: 3724930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peritoneal transport of vancomycin in 4 patients undergoing continuous ambulatory peritoneal dialysis.
    Pancorbo S; Comty C
    Nephron; 1982; 31(1):37-9. PubMed ID: 7110474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of single dose intravenous vancomycin in CAPD peritonitis.
    Whitby M; Edwards R; Aston E; Finch RG
    J Antimicrob Chemother; 1987 Mar; 19(3):351-7. PubMed ID: 3571051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacokinetics of vancomycin in chronic renal failure patients in continuous ambulatory peritoneal dialysis (CAPD) after intra-abdominal administration].
    Mounier M; Benevent D; Denis F
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):542-4. PubMed ID: 3911152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of intraperitoneal and intravenous vancomycin pharmacokinetics during continuous ambulatory peritoneal dialysis.
    Morse GD; Farolino DF; Apicella MA; Walshe JJ
    Antimicrob Agents Chemother; 1987 Feb; 31(2):173-7. PubMed ID: 3566247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraperitoneal vancomycin concentrations during peritoneal dialysis-associated peritonitis: correlation with serum levels.
    Fish R; Nipah R; Jones C; Finney H; Fan SL
    Perit Dial Int; 2012; 32(3):332-8. PubMed ID: 22045102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Removal of vancomycin by peritoneal dialysis.
    Silverman DA
    N Engl J Med; 1981 Feb; 304(6):361. PubMed ID: 7442783
    [No Abstract]   [Full Text] [Related]  

  • 12. Peritoneal pharmacokinetics of gentamicin in man.
    de Paepe M; Lameire N; Belpaire F; Bogaert M
    Clin Nephrol; 1983 Mar; 19(3):107-9. PubMed ID: 6839558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peritoneal fluid concentrations of gentamicin in patients with spontaneous bacterial peritonitis.
    Richey GD; Schleupner CJ
    Antimicrob Agents Chemother; 1981 Feb; 19(2):312-5. PubMed ID: 7347563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vancomycin pharmacokinetics during continuous ambulatory peritoneal dialysis in patients with peritonitis.
    Montañés Pauls B; Almiñana MA; Casabó Alós VG
    Eur J Pharm Sci; 2011 Jul; 43(4):212-6. PubMed ID: 21540106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vancomycin kinetics during continuous ambulatory peritoneal dialysis.
    Bunke CM; Aronoff GR; Brier ME; Sloan RS; Luft FC
    Clin Pharmacol Ther; 1983 Nov; 34(5):631-7. PubMed ID: 6627823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trough serum vancomycin levels predict the relapse of gram-positive peritonitis in peritoneal dialysis patients.
    Mulhern JG; Braden GL; O'Shea MH; Madden RL; Lipkowitz GS; Germain MJ
    Am J Kidney Dis; 1995 Apr; 25(4):611-5. PubMed ID: 7702059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous vancomycin as initial treatment for gram-positive peritonitis in patients on chronic peritoneal dialysis.
    Obermiller LE; Tzamaloukas AH; Leymon P; Avasthi PS
    Clin Nephrol; 1985 Nov; 24(5):256-60. PubMed ID: 3907908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of vancomycin in anuria.
    Cunha BA; Quintiliani R; Deglin JM; Izard MW; Nightingale CH
    Rev Infect Dis; 1981; 3 suppl():S269-72. PubMed ID: 7342290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peritoneal transport of vancomycin during peritoneal dialysis.
    Nielsen HE; Sørensen I; Hansen HE
    Nephron; 1979; 24(6):274-7. PubMed ID: 514426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of intravenous vancomycin in the treatment of gram-positive peritonitis in long-term peritoneal dialysis.
    Krothapalli RK; Senekjian HO; Ayus JC
    Am J Med; 1983 Aug; 75(2):345-8. PubMed ID: 6881188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.